chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In the days and weeks following the adminstration of the Pfizer Covid booster vaccine on December 26, 2021, I experienced increasing tingling and numbness (parasthesia) in my right hand and arm. This was accompanied by a sore/throbbing spot on the right side of my back that moved around (initially it was in my lower back, then it moved up my back, then back down my back, then towards the right side of my lower back). The tingling eventually turned into burning on my right side, particularly in my right hand and arm, but also in the lower right side of my back and in my right hip and buttock. These symptoms persisted into mid-January 2022, so I decided to see a doctor. The earliest I could see a primary care physician was on March 1, 2022.  The primary care physician referred me to a neurologist, who I first saw on April 14, 2022. Since then, I have seen two different neurologists (due to changes in my health insurance) on a number of different occasions. Over the course of the last year or so, my neurologists have ordered numerous tests described elsewhere in this report. Although they have been able to rule out various serious disorders like MLS, my case has perplexed them, and they have not been able to determine the cause of my symptoms. The burning on my right side, particularly in my hand and arm, continues to this day and can be intense at times. My neurologists have prescribed three different nerve pain medications, which have done little, if anything, to help. In addition to the burning symptoms, I now have almost no ability to sense heat or cold with my right hand (for example, I have to use my left hand to determine the temperature of water). I have also developed weakness on my right side. For example, my right arm will quickly fatigue after straining it (for example, when I use a screwdriver).  My right hand also gets very cold sometimes (not just a perceived coldness, but actual coldness). And my right hand and arm are also highly sensitive to pain (for example, if I accidentally hit my hand against something, I feel a much sharper pain than I would have before the vaccine).   I also experienced elevated blood pressure following the adminstration of the Pfizer Covid booster vaccine on December 26, 2021, and I am now taking blood pressure medication.
Client presented with rash on right upper arm and chest area.  Clietn was on the 30 min observation when the rash appeared after receiving the Covid-19 vaccine.  Client was assessed by EMT at 9:30 am.  HR 74, O2 99%.  Client was stable and cleared to leave at 10:00 am.
11am- 11pm when I went to bed. aches stabbing pains everywhere in body. Fever 99.7.  Took Advil 730pm it helped me get comfortable enough to fall asleep. Woke up next day Better.
BLOOD CLOT; HIVES;   This is a solicited report received from a contactable reporter(s) (Consumer or other non HCP) from License Party (Company). Other Case identifier(s): US-BRISTOL-MYERS SQUIBB COMPANY-2023-096396 (Company).  Information was received from a Consumer/other non health professional concerning a Female patient, enrolled in the post-marketing study who received Suspect product APIXABAN for Product used for unknown indication, lot number:Unknown. On an unknown date, the patient had thrombosis (blood clot), which met the following seriousness criteria: medical significance. It is unknown if treatment was provided. The outcome of the thrombosis was unknown. On an unknown date, the patient had urticaria (hives), which was considered non-serious. It is unknown if treatment was provided. The outcome of the urticaria was unknown. Patient stated she is currently taking Eliquis. Patient mentioned she has a developed a blood clot after taking Pfizer booster. Patient also mentioned experiencing hives during the same time. The action taken with APIXABAN medication was unknown. Concomitant medications were not reported. The reporter did not provide a causality assessment for events thrombosis and urticaria to APIXABAN. Tracking of Changes: 07-Jul-2023: Initial information was received  Eliquis is under agreement with Company.; Sender's Comments: Company Medical Evaluation Comment: This patient had thrombosis while on apixaban therapy. Based on the limited information available regarding the therapy details, event onset date, action taken with the suspect, treatment given and outcome of the event, it cannot be ascertained with the reasonable possibility that the apixaban could have contributed to the event thrombosis.
Vomiting, nausea, 104 degree fever, body aches, chills, headache, sinus pressure, ear ache, nose bleed, and high blood pressure.
10/29/2022 I began having a raspy voice. I went to the ENT doctor and they prescribed Flonase and nose drops with an antihistamine in it. I have continued to have the raspy voice since. In April I still was experiencing the raspy voice but developed a sore throat. I had a COVID test which was positive. I had an x-ray and was diagnosed with Pneumonia.
Fatigue; disjointed thoughts and speech; disjointed thoughts and speech; chills; headache; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced Fatigue, disjointed thoughts and speech, chills and headache after 2nd COVID vaccine. Awareness Date was 25Apr2021. The event outcome of unknown. Event took place after use of product. Reporter does not wish to be contacted for follow-up.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
This spontaneous report as received from a 71 years old female patient refers to herself. The patient's medical history included cancer. The patient was vaccinated with a dose of live ZOSTAVAX (route, dose and lot # were unknown) on 22-JAN-2013. No other co-suspects were reported. No concomitant medications were reported. On 24-JAN-2013 the patient woke up with indigestion pains and experienced fever, diarrhea and vomiting. No treatment was given for adverse event. The outcome of events were unknown. The relatedness for events were unknown for live ZOSTAVAX. The patient did not sought medical attention. Additional information has been requested.
AVA # 1 09 Jan 2000 Little nodule size of a nickel. No other problems noted AVA # 2 12 Feb 2000 Same as above AVA # 3 26 Feb 2000 Left arm became swollen red and hot from shoulder to wrist. He had tingling in his hand with symptoms lasting a couple of wks. He missed 1 week of work and he did file a VAERS. Reported fever and a headache. He sought medical evaluation and was placed on antibiotics. He stated that his headache lasted a couple of wks. No history of headaches. AVA # 4Subcutaneous tricep area 01 May 04 He states that he noticed slight swelling on 02 May and that the area was warm to touch. By the third the area became the size of a "grapefruit." Later that night he stated that he had increased swelling from elbow to armpit and that the area doubled in size. On 04 May the swelling extended about 2 inches below the elbow and that his lymph nodes became enlarged and tender to touch. He also reported a low-grade fever, despite taking ibuprofen regularly. He reports feeling tired and drained and a headache that is being controlled with ibuprofen. He also states that he has had itching along his arm. On 05 May he reports that his symptoms are improving.
This spontaneous report was received from a pharmacist refers to multiple patients of unknown age and gender. Concurrent conditions and medical history were not reported. On unspecified dates, the patients were vaccinated with improperly stored (temperature excursion: 34.3F, time frame: 10 hours) doses of PNEUMOVAX 23 with lot/batch# L18503, expiry date 16-MAR-2017 (dose, dose number, vaccination site and route of administration not provided). Concomitant therapies were not reported. The previous temperature excursion was reported as 48.4F for 7 hours. Product quality complaint (PQC) was not involved. This is one of three reports received from the same reporter. Additional information has been requested.
Hepatitis B vaccine given at 1657; 1707 employee complained of "feeling funny", medicine head like, "head rush" Blood pressure 129/79, pulse 78 at 1708. Complained of dry throat, given water, denied any other symptoms. Stated "feel high". Employee stated at end of reaction she had felt faint at the beginning of her reaction. 1722, employee denied any symptoms. 1735, agency notified, no further treatment needed.
1325-Patient was given 0.2mL of undiluted Pfizer (lot # FK56180 ) and monitored for 15 minutes. Patient displayed no signs of discomfort during administration, nor during monitoring period; no signs of adverse reaction. 1340-Patient left clinic with father (ambulatory,  no signs of discomfort, no signs of side effects, no sign of adverse reaction.) 1545-Med error was discovered. Appropriate managers and physicians were notified. Patient's father was notified. Father stated that child (patient) was experiencing no discomfort, nor any signs of side effects or adverse reaction. 1820-Recieved call from father requesting info in regards to signs and symptoms to monitor for. Father stated that patient was displaying no signs of adverse reaction, no side effects, no swelling or redness a injection site, no discomfort. Father stated that child had been playing all afternoon post vaccination with no report of discomfort and no change in demeanor. Follow-up call on 2/10/22 at 0945 Spoke with child's (patient's) father. Father stated that child/patient was experiencing no side effects, no sign of adverse reaction, no discomfort.
This case was reported by a nurse via call center representative and described the occurrence of itchy rash in a 21-year-old female patient who received RABAVERT (batch number 626011A, expiry date 31st March 2020). On 14th November 2016, the patient received the 1st dose of RABAVERT 1 ml. On 14th November 2016, 2 hrs after receiving RABAVERT, the patient experienced itchy rash. The patient was treated with ZYRTEC and BENADRYL. On an unknown date, the outcome of the itchy rash was unknown. The reporter considered the itchy rash to be unlikely related to RABAVERT. Additional details were provided as follows: The patient was following pre-exposure schedule for RABAVERT vaccine. At 11:30 hours, the patient received 1st dose of RABAVERT in her left deltoid and experienced a rash on her belly and her hip. The rash was described as approximately six (6) separate pencil eraser sized marks which were itchy and raised. The reporter stated these six were a total between her hip and belly with majority on her belly. The patient was advised to tale ZYRTEC or BENADRYL and to call if she had respiratory issues.
Patient came to the ED with increased shortness of breath.  Patient admitted with Covid pneumonia and treated with remdesivir.
Complaints of "tongue feeling fat"  kept additional 15 minutes.  Symptoms not worse, encouraged to call md if  symptoms got worse and to take Benadryl.  She was able to tolerate drinking water with no issues. She wanted to go home as she had worked the night before.
After vaccination reported feeling nauseous and vision was "blurry". Denied shortness of breath, did not lose consciousness.  Educated on when to seek emergency care. Pt given juice and observed 15 minutes. Pt reported she was nervous and did not eat today.  Pt left with guardian, walked out of immunization clinic.
Tinnitus began (started) due to Moderna covid vaccine taken on April 1, 2021. In taking the Jassen covid vaccine on Oct. 31, 2021, my condition of Tinnitus has worsened and level of ringing hissing frequency noise levels has increased in my head/brain.
Patient's daughter called to clinic on 5/5/23 at around 9am, reports patient is having a possible reaction from the vaccine. Fever started the morning of 5/3/23, Temperature on 5/5/23 was 103.F Starting vomiting  5/4/23 sore throat present denies shortness of breath or difficulty breathing Able to verbalize symptoms, no difficulty with speech Left arm is not swollen but is tender to touch Patient was sent to Local ED  no outcome at this time
An RN meant to give the hepatitis B vaccine. She grabbed the vaccine from the automated dispensing cabinet fridge, gave them medication, and then scanned it AFTER it was administered to document as given. When scanned, the RN realized she gave the wrong vaccine. Since this vaccine is not indicated in patients < 6 months of age, she notified her supervisors and called pharmacy for recommendations. Poison control was contacted and did not recommend any intervention as long as the patient remained asymptomatic. There was swelling bilaterally on the anterolatera thighs. All vital signs were normal and check Q1hr x 6 times.
Bloody noses anywhere from 1 to 3 per day, every day since the immunization was administered up through the 28th, when he had 2 bloody noses.  While he can get a bloody nose that will bleed from the same spot for a couple of days until healed, he has never had bloody noses for 10 days straight before.
Excruciating pain soon after. Arm has been sore ever since. Doctor said pharmacist hit a nerve. He said I was injured. It has been 4 weeks. I have had much discomfort and had to pay $20 to my Dr.
Dry Mouth; Dizziness; Headache; Pain in Left Hand ( This was the hand where the shot was administered); This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry Mouth), DIZZINESS (Dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Pain in Left Hand ( This was the hand where the shot was administered)) in a 43-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Dec-2021, the patient experienced DRY MOUTH (Dry Mouth), DIZZINESS (Dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Pain in Left Hand ( This was the hand where the shot was administered)). At the time of the report, DRY MOUTH (Dry Mouth), DIZZINESS (Dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Pain in Left Hand ( This was the hand where the shot was administered)) outcome was unknown.            Concomitant medication information was not provided by the reporter.                            Treatment information was not provided by the reporter.   This case was linked to MOD-2021-406420, MOD-2021-406421 (Patient Link).
Patient had not received any Covid vaccines prior to 4/20/23. Patient received Moderna from pink cap vial. Brown bag vial was in stated 6mos.-5yrs. Patient should have received Moderna from blue cap vial. The brown bag the blue cap vial was in stated 6 yrs.-11 yrs.
dizziness; fever; chills; nervousness; Headache; sleepiness/drowsiness; shaking; diarrhea; This is a spontaneous report from a contactable consumer (the patient).   A 40-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 06Mar2021 16:00 (Batch/Lot Number: Pfizer EL9267) as single dose for covid-19 immunisation (Age at vaccination 40 years) .  Medical history included penicillin hypersensitivity. Concomitant medications included ergocalciferol (VIT D) taken for an unspecified indication, start and stop date were not reported.  On 13Feb2021 the patient received the first dose of BNT162B2 vaccine (Lot #Pfizer EN5318). The patient experienced dizziness  on 07Mar2021 09:00 with outcome of recovering , fever  on 07Mar2021 09:00 with outcome of recovering , chills on 07Mar2021 09:00 with outcome of recovering , nervousness  on 07Mar2021 09:00 with outcome of recovering , headache  on 07Mar2021 09:00 with outcome of recovering , sleepiness/drowsiness  on 07Mar2021 09:00 with outcome of recovering , shaking  on 07Mar2021 09:00 with outcome of recovering , diarrhea on 07Mar2021 09:00 with outcome of recovering.   The patient received paracetamol (TYLENOL), increased fluid intake and bed rest as treatment of the events.  No follow-up attempts are possible. No further information is expected.
Patient had a left sided segmental and subsegmental pulmonary embolism, severe back pain, dyspnea, tachycardia and tachypnea, started on 6/24.
1.mild sore throat started on 3/20/23- 2. extreme sore throat, chills, brain fog, dizziness, nausea, fatigue on 3/23/23 3. 3/23/23 called Dr.'s office to get treatment., I was told the doctor does not treat covid. I asked what should I do, they said it was like the common cold. I asked how long should I isolate and they told me they did not know the recommendations at this time and laughed. They told me to rest and look up isolation recommendations on line.  4. 3/24 symptoms became worse, extreme nausea, dizziness, fatigue, non stop chills, sore throat was so bad I was gagging on spit in my sleep. Difficult sleepy and confusion. blood ox was down from 99 to 95.  5. 3/25 My neighbor who is a doctor prescribed paxlovid. I did not go to a doctors office. They called it in to. a pharmacy and picked it up for me. blood ox was 95. Could not eat. Fluid and popsicles. Ate a little rice.  6. 3/26 blood ox was ranging from 90-95. Nieghbor doctor advised I go to ER. Blood ox was increased at ER up to high 90s. They sent me home and told me to continue paxlovid. Very confused, worst sore throat of my life, chills would not stop, nausea was very bad could not eat. Only drinking fluids and popsicles. Ate rice and apple sauce. Slept on and off for 18 hours.  7. 3/27 Similar symptoms to 3/26, blood ox was higher 98 -99.  tested positive for 9 days.  I am on week 3 still light headed, coughing and congestion with brain fog.
Approximately 12 hours later she developed a fever/feeling warm; Approximately 12 hours later she developed a fever, headache, and cold like symptoms; cold like symptoms/cold for the past 2 days; a bit of a migraine; This is a spontaneous report from a contactable consumer (patient).   A 21-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 05Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient's medical history and concomitant medications was not reported. Approximately 12 hours after vaccination in Apr2021, patient developed a fever, headache, and cold like symptoms. Patient said the first day she had no reaction to the vaccine. She said she went to sleep that night, and in the middle of the night she awoke and was feeling warm in Apr2021. She said she had a cold for the past 2 days, and a bit of a migraine, both in Apr2021. She wants to know how long these side effects could last and why do some people not experience side effects. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
chills; shaking; limb heaviness; cold feeling; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender receive the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. After the second Covid vaccine about 12 hrs later the patient experienced chills, shaking, limb heaviness and was extremely cold feeling. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Aspiration pneumonia; A spontaneous report  was received from a consumer concerning 79-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and developed Aspiration pneumonia (Pneumonia aspiration).    The patient's medical history included 3 episodes of aspiration pneumonia before vaccination. Concomitant product use was not provided by the reporter.       On 15 Feb 2021, approximately 4 days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Lot number-Unknown ) via unknown route in the right arm for prophylaxis of COVID-19 infection.   On 19 Feb 2021, the patient was diagnosed with aspiration pneumonia. The event Pneumonia aspiration was medically significant.   Treatment for the event included antibiotics.      Action taken with mRNA-1273 in response to the event was not reported.  On an unknown date, the event aspiration pneumonia, was considered resolved.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Immediately after the vaccine, my arm started burning in my neck and opposite arm joints became very sore throughout the day my entire body became extremely sore and I developed an ear ache and a headache and I am very fatigued. Today is the 17th of the month and that your aching headache still has not always go away. I?m not sure if this is a normal reaction or not.
Fever 100.8, Pouring sweat all night long--range April 11, 2021 approx 10pm  through April12 through 10 am.  Fever 99.8,  Tingling Zaps electrial impulses between temples of forehead from 3 am on 4/12/2021 continues still at 2:01 pm. Headache Contines from 4/10/2021 to present time.  Nausea, all day 04/11/2021 all day long Heart Palpitations, 04/11/2021--3 pm to 5 pm & again 9 pm to 11 pm and continued again 04/12/2021 7 am to 11 am
When the 1st shot was given, I felt extremely tired and sleepy; When the 1st shot was given, I felt extremely tired and sleepy; My arm also hurt for days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Jul2021 at 17:00 as dose 1, single (Lot number: EW0181) at the age of 43 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Known allergies: Milk" (unspecified if ongoing); "Known allergies: Rice" (unspecified if ongoing); "Known allergies: Elderberry" (unspecified if ongoing); "Known allergies: Corn" (unspecified if ongoing); "Known allergies: Sensative to Elm" (unspecified if ongoing); "Known allergies: Red and green dye" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: FATIGUE (non-serious), SOMNOLENCE (non-serious), all with latency 8 months 13 days 15 hrs after the suspect product(s) administration, outcome "unknown" and all described as "When the 1st shot was given, I felt extremely tired and sleepy"; PAIN IN EXTREMITY (non-serious), 8 months 13 days 15 hrs after the suspect product(s) administration, outcome "unknown", described as "My arm also hurt for days".  Additional information: Patient did not receive any other vaccine in four weeks. Other medications in two weeks reported as Seamoss. It was reported that 1 year later injection site had a bubble that never went away. It started oozing dried dark puss today until the small bubble went away completely. When the 1st shot was given, the patient felt extremely tired and sleepy. Her arm also hurt for days. Patient did not have COVID prior vaccination. Patient was not tested for COVID post vaccination.  No follow-up attempts are possible. No further information is expected.